These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34470779)

  • 1. Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression.
    Park S; Rong L; Owczarek TB; Bernardo MD; Shoulson RL; Chua CW; Kim JY; Lankarani A; Chakrapani P; Syed T; McKiernan JM; Solit DB; Shen MM; Al-Ahmadie HA; Abate-Shen C
    Cancer Res; 2021 Oct; 81(20):5161-5175. PubMed ID: 34470779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of p53 and Pten promotes invasive bladder cancer.
    Puzio-Kuter AM; Castillo-Martin M; Kinkade CW; Wang X; Shen TH; Matos T; Shen MM; Cordon-Cardo C; Abate-Shen C
    Genes Dev; 2009 Mar; 23(6):675-80. PubMed ID: 19261747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma.
    Ayala de la Peña F; Kanasaki K; Kanasaki M; Tangirala N; Maeda G; Kalluri R
    J Biol Chem; 2011 Jun; 286(23):20778-87. PubMed ID: 21388952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.
    Bex A; Vooijs M; Horenblas S; Berns A
    J Urol; 2002 Dec; 168(6):2641-4. PubMed ID: 12442001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression.
    Piao XM; You C; Byun YJ; Kang HW; Noh J; Lee J; Lee HY; Kim K; Kim WT; Yun SJ; Lee SC; Kang K; Kim YJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients.
    Tsuruta H; Kishimoto H; Sasaki T; Horie Y; Natsui M; Shibata Y; Hamada K; Yajima N; Kawahara K; Sasaki M; Tsuchiya N; Enomoto K; Mak TW; Nakano T; Habuchi T; Suzuki A
    Cancer Res; 2006 Sep; 66(17):8389-96. PubMed ID: 16951148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.
    Mo Q; Nikolos F; Chen F; Tramel Z; Lee YC; Hayashi K; Xiao J; Shen J; Chan KS
    J Natl Cancer Inst; 2018 May; 110(5):448-459. PubMed ID: 29342309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer.
    Lokeshwar VB; Morera DS; Hasanali SL; Yates TJ; Hupe MC; Knapp J; Lokeshwar SD; Wang J; Hennig MJP; Baskar R; Escudero DO; Racine RR; Dhir N; Jordan AR; Hoye K; Azih I; Manoharan M; Klaassen Z; Kavuri S; Lopez LE; Ghosh S; Lokeshwar BL
    Clin Cancer Res; 2020 Jul; 26(13):3455-3467. PubMed ID: 32094233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
    Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
    J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of urothelial tumorigenesis: insights from genetically engineered mice.
    Wu XR
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):281-90. PubMed ID: 20012171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.
    Kim WJ; Kim EJ; Kim SK; Kim YJ; Ha YS; Jeong P; Kim MJ; Yun SJ; Lee KM; Moon SK; Lee SC; Cha EJ; Bae SC
    Mol Cancer; 2010 Jan; 9():3. PubMed ID: 20059769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
    Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
    Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.
    Osei-Amponsa V; Buckwalter JM; Shuman L; Zheng Z; Yamashita H; Walter V; Wildermuth T; Ellis-Mohl J; Liu C; Warrick JI; Shantz LM; Feehan RP; Al-Ahmadie H; Mendelsohn C; Raman JD; Kaestner KH; Wu XR; DeGraff DJ
    Oncogene; 2020 Feb; 39(6):1302-1317. PubMed ID: 31636388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
    Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
    Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy.
    Kim WT; Kim J; Yan C; Jeong P; Choi SY; Lee OJ; Chae YB; Yun SJ; Lee SC; Kim WJ
    Ann Oncol; 2014 May; 25(5):974-9. PubMed ID: 24631944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
    Wu X; Lv D; Cai C; Zhao Z; Wang M; Chen W; Liu Y
    Front Immunol; 2020; 11():590618. PubMed ID: 33391264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.
    Daizumoto K; Yoshimaru T; Matsushita Y; Fukawa T; Uehara H; Ono M; Komatsu M; Kanayama HO; Katagiri T
    Cancer Res; 2018 May; 78(9):2233-2247. PubMed ID: 29440146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
    Roudnicky F; Dieterich LC; Poyet C; Buser L; Wild P; Tang D; Camenzind P; Ho CH; Otto VI; Detmar M
    J Pathol; 2017 Jun; 242(2):193-205. PubMed ID: 28295307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.